Rhode Island S2890 mandates health insurance coverage for hormonal and non-hormonal therapies to treat peri-menopause and menopause symptoms.

Rhode Island S2890 requires health insurers to cover medically necessary hormonal and non-hormonal therapies for peri-menopause and menopause symptoms, including oral, transdermal, topical, and vaginal ring administration. This coverage applies if the therapy is recommended by a qualified healthcare provider licensed in Rhode Island and has been proven safe and effective. The mandate takes effect for all insurance policies issued on or after January 1, 2027.

Rhode Island S2890 mandates health insurance coverage for hormonal and non-hormonal therapies to treat peri-menopause and menopause symptoms.

Rhode Island S2890 requires health insurers to cover medically necessary hormonal and non-hormonal therapies for peri-menopause and menopause symptoms, including oral, transdermal, topical, and vaginal ring administration. This coverage applies if the therapy is recommended by a qualified healthcare provider licensed in Rhode Island and has been proven safe and effective. The mandate takes effect for all insurance policies issued on or after January 1, 2027.